105 related articles for article (PubMed ID: 31328852)
1. Role of the cytosolic domain of occludin in trafficking and hepatitis C virus infection.
Lavie M; Linna L; Moustafa RI; Belouzard S; Fukasawa M; Dubuisson J
Traffic; 2019 Oct; 20(10):753-773. PubMed ID: 31328852
[TBL] [Abstract][Full Text] [Related]
2. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
[TBL] [Abstract][Full Text] [Related]
3. MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA.
Sendi H; Mehrab-Mohseni M; Foureau DM; Ghosh S; Walling TL; Steuerwald N; Zamor PJ; Kaplan KJ; Jacobs C; Ahrens WA; Russo MW; Clemens MG; Schrum LW; Bonkovsky HL
Liver Int; 2015 Apr; 35(4):1315-23. PubMed ID: 25302477
[TBL] [Abstract][Full Text] [Related]
4. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.
Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007
[TBL] [Abstract][Full Text] [Related]
5. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies.
Sourisseau M; Michta ML; Zony C; Israelow B; Hopcraft SE; Narbus CM; Parra Martín A; Evans MJ
PLoS Pathog; 2013 Mar; 9(3):e1003244. PubMed ID: 23555257
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model.
Shimizu Y; Shirasago Y; Kondoh M; Suzuki T; Wakita T; Hanada K; Yagi K; Fukasawa M
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437969
[TBL] [Abstract][Full Text] [Related]
7. Occludin stalls HCV particle dynamics apart from hepatocyte tight junctions, promoting virion internalization.
Deffieu MS; Clément CMH; Dorobantu CM; Partiot E; Bare Y; Faklaris O; Rivière B; Ayala-Nunez NV; Baumert TF; Rondé P; Mély Y; Lucansky V; Gaudin R
Hepatology; 2022 Oct; 76(4):1164-1179. PubMed ID: 35388524
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C Virus Disrupts Annexin 5-Mediated Occludin Integrity through Downregulation of Protein Kinase Cα (PKCα) and PKCη Expression, Thereby Promoting Viral Propagation.
Abe T; Marutani Y; Deng L; Matsui C; Fukasawa M; Suzuki R; Wakita T; Matsuura Y; Shoji I
J Virol; 2023 Jun; 97(6):e0065523. PubMed ID: 37272842
[TBL] [Abstract][Full Text] [Related]
9. Occludin-Knockout Human Hepatic Huh7.5.1-8-Derived Cells Are Completely Resistant to Hepatitis C Virus Infection.
Shirasago Y; Shimizu Y; Tanida I; Suzuki T; Suzuki R; Sugiyama K; Wakita T; Hanada K; Yagi K; Kondoh M; Fukasawa M
Biol Pharm Bull; 2016 May; 39(5):839-48. PubMed ID: 26887345
[TBL] [Abstract][Full Text] [Related]
10. The second extracellular loop dictates Occludin-mediated HCV entry.
Liu S; Kuo W; Yang W; Liu W; Gibson GA; Dorko K; Watkins SC; Strom SC; Wang T
Virology; 2010 Nov; 407(1):160-70. PubMed ID: 20822789
[TBL] [Abstract][Full Text] [Related]
11. Species-specific regions of occludin required by hepatitis C virus for cell entry.
Michta ML; Hopcraft SE; Narbus CM; Kratovac Z; Israelow B; Sourisseau M; Evans MJ
J Virol; 2010 Nov; 84(22):11696-708. PubMed ID: 20844048
[TBL] [Abstract][Full Text] [Related]
12. Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.
Fénéant L; Ghosn J; Fouquet B; Helle F; Belouzard S; Vausselin T; Séron K; Delfraissy JF; Dubuisson J; Misrahi M; Cocquerel L
PLoS One; 2015; 10(11):e0142539. PubMed ID: 26561856
[TBL] [Abstract][Full Text] [Related]
13. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection.
Liu S; Yang W; Shen L; Turner JR; Coyne CB; Wang T
J Virol; 2009 Feb; 83(4):2011-4. PubMed ID: 19052094
[TBL] [Abstract][Full Text] [Related]
14. Single Particle Imaging of Polarized Hepatoma Organoids upon Hepatitis C Virus Infection Reveals an Ordered and Sequential Entry Process.
Baktash Y; Madhav A; Coller KE; Randall G
Cell Host Microbe; 2018 Mar; 23(3):382-394.e5. PubMed ID: 29544098
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum.
Benedicto I; Molina-Jiménez F; Barreiro O; Maldonado-Rodríguez A; Prieto J; Moreno-Otero R; Aldabe R; López-Cabrera M; Majano PL
Hepatology; 2008 Oct; 48(4):1044-53. PubMed ID: 18802961
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition.
Li Q; Sodroski C; Lowey B; Schweitzer CJ; Cha H; Zhang F; Liang TJ
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7620-5. PubMed ID: 27298373
[TBL] [Abstract][Full Text] [Related]
17. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.
Benedicto I; Molina-Jiménez F; Bartosch B; Cosset FL; Lavillette D; Prieto J; Moreno-Otero R; Valenzuela-Fernández A; Aldabe R; López-Cabrera M; Majano PL
J Virol; 2009 Aug; 83(16):8012-20. PubMed ID: 19515778
[TBL] [Abstract][Full Text] [Related]
18. Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry.
Kohaar I; Ploss A; Korol E; Mu K; Schoggins JW; O'Brien TR; Rice CM; Prokunina-Olsson L
J Virol; 2010 Jul; 84(14):6987-94. PubMed ID: 20463075
[TBL] [Abstract][Full Text] [Related]
19. Fusion expression of Occludin extracellular loops and an α-helical bundle: A new research model for tight junction.
Chi X; Zhao X; Wang W; Niu Y; Cheng M; Liu X; Cui S; Yang W
PLoS One; 2017; 12(4):e0175516. PubMed ID: 28448574
[TBL] [Abstract][Full Text] [Related]
20. Occludin-binding single-chain variable fragment and antigen-binding fragment antibodies prevent hepatitis C virus infection.
Shimizu Y; Shinoda T; Shirasago Y; Kondoh M; Shinya N; Hanada K; Yagi K; Suzuki T; Wakita T; Kimura-Someya T; Shirouzu M; Fukasawa M
FEBS Lett; 2021 Jan; 595(2):220-229. PubMed ID: 33113151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
